InsidersTradesSigma
Explore the detailed record of transactions filed by Dexcel Pharma Technologies Ltd.. Officer active across 2 companies, notably Protalix BioTherapeutics, Inc.. In total, 3 reports have been recorded. Total volume traded: €368k. The latest transaction was disclosed on 22 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations